In case you missed it: April 5 to April 9

This week’s top articles included:

Osterholm: B.1.1.7 variant poses challenge to in-school education

Michael Osterholm, PhD, MPH, warns that the B.1.1.7 variant of coronavirus disease 2019 could necessitate a return to at-home school because of the variant’s impact on children.

FDA approves non-stimulant Qelbree to treat ADHD

The US Food and Drug Administration (FDA) approves first novel non-stimulant medication to treat attention-deficit/hyperactivity disorder (ADHD) in children in a decade.

Do EBT cards improve WIC participation?

An investigation examines whether moving from paper vouchers to electronic benefits transfer (EBT) cards improved participation numbers for Special Supplemental Nutrition Program for Women, Infants, and Children (WIC).

How the pandemic has impacted how HCPs view their career path and development

The past year has seen a lot of celebrating of health care professionals (HCPs) for their relentless work during the pandemic, but how are they feeling about their career path and potential for development now? A study offers some answers.